UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027120
Receipt number R000030460
Scientific Title Exhaustive examination about the cause microbe diagnosis of the fever case in newborn infants.
Date of disclosure of the study information 2017/04/25
Last modified on 2020/06/08 16:53:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exhaustive examination about the cause microbe diagnosis of the fever case in newborn infants.

Acronym

Examination about the cause microbe of the fever case in newborn infants.

Scientific Title

Exhaustive examination about the cause microbe diagnosis of the fever case in newborn infants.

Scientific Title:Acronym

Examination about the cause microbe of the fever case in newborn infants.

Region

Japan


Condition

Condition

Fever case in newborn infants

Classification by specialty

Pediatrics Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Exhaustive examination about the cause microbe diagnosis of the fever case in newborn infants.

Basic objectives2

Others

Basic objectives -Others

Choice of appropriate antimicrobial or antifungus in the fever case in newborn infants

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

16SrRNA or 18SrRNA detected from serum and Nasopharyngeal swabs

Key secondary outcomes

Identification of the cause microbe


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

0 months-old <=

Age-upper limit

3 months-old >

Gender

Male and Female

Key inclusion criteria

Inpatients in newborn infant of fever cases.

Key exclusion criteria

The fever continuation patient who are transferred from other hospital.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuhei Tanaka

Organization

Department of Pediatrics Kawasaki Medical School

Division name

Pediatrics

Zip code


Address

577 Matsushima, Kurashiki, Okayama, Japan 701-0192

TEL

0864621111

Email

yuhei.tuk.first@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Yuhei Tanaka

Organization

Department of Pediatrics Kawasaki Medical School

Division name

Pediatrics

Zip code


Address

577 Matsushima, Kurashiki, Okayama, Japan 701-0192

TEL

0864621111

Homepage URL


Email

yuhei.tuk.first@gmail.com


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

Kawasaki Medical School

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 04 Month 25 Day

Date of IRB

2017 Year 05 Month 08 Day

Anticipated trial start date

2017 Year 06 Month 01 Day

Last follow-up date

2020 Year 05 Month 07 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2020 Year 05 Month 07 Day


Other

Other related information

None


Management information

Registered date

2017 Year 04 Month 25 Day

Last modified on

2020 Year 06 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030460


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name